SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results
13 août 2024 06h00 HE
|
SANUWAVE Health, Inc.
Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income...
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results
07 août 2024 18h51 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will...
SANUWAVE Announces Record Q4 and FY2023 Revenue
22 mars 2024 06h00 HE
|
SANUWAVE Health, Inc.
Q4 2023 revenues were a record $7.0 million, up 27% from Q4 2022 FY 2023 revenues were a record $20.4 million, up 22% from FY2022 Operating income was $1 million for Q4 2023 compared to an operating...
SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results
20 mars 2024 07h00 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, March 20, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound...
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
22 févr. 2024 17h00 HE
|
SANUWAVE Health, Inc.
At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 “for” and 5,221,765 “against”...
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023
10 janv. 2024 07h00 HE
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $6.6 million to $6.8 million for the fourth quarter ended December 31, 2023. This represents a new quarterly revenue record for the Company. Q4...
SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023
10 oct. 2023 07h30 HE
|
SANUWAVE Health, Inc.
SANUWAVE is Pleased to Announce Preliminary Revenues of $4.7 Million to $4.9 Million for the Third Quarter Ended September 30, 2023 Results Indicate 13-18% Growth Rate Over Q3 2022 UltraMist...
SANUWAVE Health Appoints Industry Veteran Andrew Walko as President
31 juil. 2023 07h30 HE
|
SANUWAVE Health, Inc.
Walko brings 17 years of Manufacturing, Production, Operations, and Logistics Experience, most recently as President of Biomerics, where he led a 170-person contract manufacturing organization EDEN...
SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter Ended June 30, 2023
17 juil. 2023 07h30 HE
|
SANUWAVE Health, Inc.
SANUWAVE is pleased to announce preliminary revenues of $4.5 million to $4.7 million for Q2 ended June 30, 2023 Results indicate 16-21% growth rate over Q2 2022, consistent with guidance provided...
SANUWAVE’s Energy First Technology to be Featured in 3 Clinical Posters at Upcoming 2022 Fall Symposium on Advanced Wound Care (SAWC)
12 oct. 2022 08h00 HE
|
SANUWAVE Health, Inc.
EDEN PRAIRIE, MN, Oct. 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (OTCPK: SNWV), a leading provider of next-generation wound care products, is excited to announce that...